MicrosoftExpanded
Roche modernizes breast cancer diagnostics with Azure-based AI
Use case typeMedical imagingUpdated Jun 13, 2026
Roche has deployed artificial intelligence solutions such as uPath Ki-67, ER, and PR digital pathology algorithms to automate tumor marker analyses. Integrated with Roche's uPath NAVIFY platform, these tools enhance diagnostic precision while reducing manual workload for breast cancer pathologists.
- Organization
- Roche
- Industry
- Healthcare
- Location
- United States
- Published
- December 2021
Reported outcomes
Strategic outcomes
New product / capabilityAutomated tumor marker analysisBetter decisions & insightImproved diagnostic precisionCustomer experience & trustHigher diagnostic consistencyEmployee experienceReduced manual workload
Primary read
Use case focus
Showing 2 of 2
- 1AI-enhanced pathology analysis
- 2Cancer diagnostic automation
- Manual complexity in tumor marker analysis
- Need for higher diagnostic precision
- Long turnaround time in pathology reports
- Integration of AI-based uPath Ki-67, ER, and PR algorithms
- Utilization of Azure-based NAVIFY Digital Pathology platform
- Deep learning for analyzing whole-slide imaging
Technologies
- Faster tumor marker analysis
- Higher diagnostic consistency
- Enhanced pathologist confidence due to AI integration
Architecture
Pathology imaging is analyzed using Azure AI and deep learning models via Roche's uPath NAVIFY platform.
Sources & evidence1
ExpandedExpanded
The same organization appears in newer AI deployment evidence.
- Same organization re-documented as recently as 2025.
- Cited source last checked Jun 12, 2026 — ok (0/1 broken).
Measures whether this deployment's public evidence persists — not whether the system is still in production.
Groundedness: Unavailable
AI-generated summary. Verify important details with the linked sources before relying on this case.
Explore related AI use cases
Provider evidence
AI patterns
Browse the catalog